期刊文献+

甘蔗蜡提取物多廿烷醇的降血脂机制研究 被引量:2

Study on the Hypolipidemic Mechanism of Policosanol Extracted from Sugarcane Wax
下载PDF
导出
摘要 采用RT-PCR、Western Blot、L-[35S]放射性标记物掺入等方法,观察甘蔗蜡提取物多廿烷醇对HepG2细胞羟甲基戊二酸辅酶A(HMG-CoA)还原酶mRNA转录及蛋白质表达量的影响,及其对HMG-CoA还原酶合成和降解的作用。结果表明,多廿烷醇降低HMG-CoA还原酶mRNA的转录和蛋白质的表达量,且作用效果随多廿烷醇浓度的升高而增强。此外,多廿烷醇抑制HMG-CoA还原酶的合成并加速其降解,多廿烷醇处理后HMG-CoA还原酶的半衰期明显缩短。 The effects of policosanol extracted from sugarcane wax on mRNA transcription and protein expression level,synthesis and degeneration of 3-hydroxy-3-methylglutarl-coenzyme(HMG-CoA) reductase in Hep G2 cell were determined by RT-PCR,Western Blot and L- radioactive isotope tracing technology.The results showed that the mRNA transcription and protein expression level of HMG-CoA reductase decreased with the increase of policosanol concentration(10,20,30 μg/L).Policosanol also suppressed the synthesis of HMG-CoA reductases while sped up its degeneration;the half life of HMG-CoA reductases treated by policosanol was shortened obviously.
作者 廖芳 陈伟伟
出处 《湖北农业科学》 北大核心 2013年第5期1125-1128,共4页 Hubei Agricultural Sciences
关键词 多廿烷醇 HEP G2细胞 羟甲基戊二酸辅酶A(HMG-CoA)还原酶 policosanol Hep G2 cell 3-hydroxy-3-methylglutarl-coenzyme(HMG-CoA) reductase
  • 相关文献

参考文献8

  • 1胡大一,丁荣晶.新型调脂药——多廿烷醇临床应用评价[J].中国实用内科杂志,2009,29(1):17-19. 被引量:11
  • 2BANERJEE S,GHOSHAL S,PORTER T D.Activation of AMP-kinase by policosanol requires peroxisomal metabolismLipids,2011.
  • 3Davidson MH.Rosuvastatin:a highly eficacious statin for the treatment of dyslipidaemiaExpert Opinion on Investigational Drugs,2002.
  • 4Menendez R,Marrero D,Mas R,et al.In Vitro and In Vivo Study of Octacosanol MetabolismArchives of Medical Research,2005.
  • 5Castano G,Mas R,Fernandez JC,Fernandez L,Illnait J,Lopez E.Effects of policosanol on older patients with hypertension and type II hypercholesterolaemiaDrugs R D,2002.
  • 6Singh D K,,Li L,Porter T D.Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinaseJournal of Pharmacology and Experimental Therapeutics,2006.
  • 7MAS R,CASTANO G,FEMANDEZ J,et al.Long-term effects of policosanol on obese patients with type II hypercholesterolemiaAsia Pac J Clin Nutr,2004.
  • 8Farmer J A,Gotto A M.Choosing the right lipid-regulating agent: a guide to selectionDrugs,1996.

二级参考文献7

  • 1Singh DK, Li L, Porter TD. Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase [ J ]. J Pharmacol Exp Ther,2006,318 ( 3 ) : 1020 - 1026.
  • 2Fernamdez S,Mas R, Gamez R,et al. A pharmacological surveillance study of the tolerability of policosanol in the elderly population [ J ]. Am J Geriatr Pharmacother,2004,2 ( 4 ) :219 - 229.
  • 3Castano G, Fernandez L, Mas R, et al. Comparison of the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidaemia and type 2 diabetes mellitus [ J ]. Chn Drug Investig,2003,23 (10) :639 -650.
  • 4Dulin MF, Hatcher LF, Sasser HC, et al. Policosanol is ineffective in the treatment of hypereholesterolemia: a randomized controlled trial[J]. Am J Clin Nutr,2006,84(6) :1543 - 1548.
  • 5Berthold HK, Unverdorben S, Degenhardt R, et al. Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial [ J ]. JAMA ,2006,295 ( 19 ) :2262 - 2269.
  • 6Cubeddu LX, Cubeddu R J, Heimowitz T, et al. Comparative lipidlowering effects of policosanol and atorvastatin : a randomized narallel, double-blind, placebo-controlled trial [ J ]. Am Heart J, 2006, 152(5 ) :982, e1- e5.
  • 7王云,柯元南,王嘉莉,焦媛,赵秀丽,孙宁玲,杨新春,孙瑞华.多廿烷醇与普伐他汀治疗高脂血症的疗效和安全性[J].中国新药与临床杂志,2008,27(2):124-128. 被引量:12

共引文献12

同被引文献11

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部